Skip to main content
. 2019 Jun 7;21(11):2614–2630. doi: 10.1038/s41436-019-0563-5

Table 3.

Ten most commonly identified genetic variants causing deafness

Gene Variant Diagnostic frequency (n alleles) % of diagnosed variants
MORL
STRC CNV—partial/whole-gene deletion 84 11.8%
GJB2 c.35delG, p.Gly12fs 51 7.1%
GJB2 c.109G>A, p.Val37Ile 27 3.8%
GJB2 c.101T>C, p.Met34Thr 20 2.8%
OTOA CNV—partial/whole-gene deletion 7 1.0%
USH2A c.4714C>T, p.Leu1572Phe 7 1.0%
USH2A c.2299delG, p.Glu767fs 7 1.0%
SLC26A4 c.1001+1G>A 6 0.8%
GJB2 c.167delT, p.Leu56fs 5 0.7%
MYO7A c.3719G>A, p.Arg1240Gln 4 0.6%
MORL total 218 30.5%
LMM
GJB2 c.35delG, p.Gly12fs 196 14.3%
GJB2 c.109G>A, p.Val37Ile 131 9.6%
STRC CNV—partial/whole-gene deletion 110 8.0%
GJB2 c.101T>C, p.Met34Thr 49 3.6%
USH2A c.2299delG, p.Glu767fs 38 2.8%
GJB2 c.167delT, p.Leu56fs 17 1.2%
GJB2 c.−23+1G>A 13 1.0%
GJB2 c.269T>C, p.Leu90Pro 13 1.0%
GJB2 c.313_326del, p.Lys105fs 11 0.8%
GJB2 GJB6-deletion upstream 10 0.7%
LMM total 588 43.0%

Ten variants most commonly identified as causes of deafness in two clinical testing laboratories: Molecular Otolaryngology & Renal Research Labs (MORL, Iowa City, IA) and the Laboratory for Molecular Medicine (LMM, Cambridge, MA). MORL data are from 2460 individuals from the US population with deafness who presented for diagnostic comprehensive genetic testing with the OtoSCOPE platform. The total number of diagnoses provided is 982, or 39.9% of 2460. All ethnicities are included and no exclusions were made based on type of deafness (R.J.S., unpublished data). LMM data are from 737 diagnosed cases mainly from the US population with deafness who presented for diagnostic genetic testing at the LMM. GJB2-related deafness was overrepresented because 104 cases were only tested for GJB2 including deletions of 5’ upstream regulatory regions involving GJB6. Data from MORL are adapted from Sloan-Heggen et al. (2016);13 data from LMM are unpublished (contributed by S.A. and J.S.).

CNV copy-number variant.